Adolore Biotherapeutics has filed a notice of an exempt offering of securities to raise $1,055,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Adolore Biotherapeutics is raising up to $1,055,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Roelof Rongen played a…